NCT07677891 Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus Status NOT_YET_RECRUITING Phase PHASE2
NCT07668336 A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes Status NOT_YET_RECRUITING Phase PHASE3
NCT07619495 Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk Status COMPLETED Phase N/A
NCT07537088 Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT07417631 Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data. Status COMPLETED Phase N/A
NCT07417618 INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD) Status COMPLETED Phase N/A
NCT07319286 Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT07313813 A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT07282041 Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis Status RECRUITING Phase PHASE2/PHASE3
NCT07096063 Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk Status COMPLETED Phase N/A
NCT07088718 Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data Status COMPLETED Phase N/A
NCT06851962 Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06779929 Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Status COMPLETED Phase N/A
NCT06739122 A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) Status RECRUITING Phase PHASE3
NCT06611904 The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria Status ACTIVE_NOT_RECRUITING Phase NA
NCT06257966 A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06235086 A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT05946148 Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) Status COMPLETED Phase N/A
NCT05680129 A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM Status COMPLETED Phase PHASE3